Send me a link:

*Text messaging rates may apply.

 Dow Up 0.17% Nasdaq Up 0.44%

Cytokinetics, Incorporated (CYTK)

-NasdaqCM
4.60 Up 0.31(7.23%) Jul 11, 4:00PM EDT
Prev Close:4.29
Open:4.29
Bid:4.15 x 2000
Ask:4.76 x 2000
1y Target Est:10.33
Beta:0.99
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:4.29 - 4.69
52wk Range:3.96 - 14.20
Volume:663,826
Avg Vol (3m):1,054,580
Market Cap:168.40M
P/E (ttm):N/A
EPS (ttm):-1.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTK

Comparison

Symbol% ChgMkt Cap
CYTKUp 7.23%168.40M
BIIBUp 0.97%76.43B
LGNDUp 0.70%1.32B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.15
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.16
Quarterly EPS Est (Jun-14) :-0.32
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-0.25

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditi... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback